{
    "SPADE_UN_10699": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 7811577 B2",
                "Patent Link": "http://www.lens.org/lens/patent/US_7811577_B2",
                "Patent Type": "Granted Patent",
                "Publication Date": "2010-10-12",
                "Family Info": "CA2567030A1,EP1755667A2,EP1755667A4,EP2354153A2,EP2354153A3,US20070224212,WO2005118886A2,WO2005118886A3",
                "Patent Title": "Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity.",
                "Abstract": "Methods of covalently-stabilizing alpha-helical, chimeric peptides constrained within a homotrimeric or heterotrimeric coiled-coil structure are disclosed. The coiled-coil structures made by the methods disclosed within this specification mimic all or a portion of the internal, trimeric coiled-coil motif contained within the fusogenic conformation of an enveloped virus membrane-fusion protein, particularly the internal coiled-coil domain of the HIV gp41 ectodomain. The HIV-derived, chimeric peptides disclosed comprise a non-HIV, soluble, trimeric form of a coiled-coil fused in helical phase to all or a portion of the N-helix of HIV gp41 and are covalently-stabilized in a homotrimeric or heterotrimeric coiled-coil structure through the formation of disulfide or chemoselective bonds between said peptides. The covalently-stabilized, HIV-derived, homotrimeric or heterotrimeric coiled-coil structures made by the methods disclosed herein represent a close mimetic of a HIV gp41 fusion intermediate and ar"
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_10699",
            "Sequence": "CCGGIKKEIEAIKKEQEAIKKKIEAIEKLLQLTVWGIKALAAAIA",
            "Sequence Length": 45,
            "Peptide Name": "Sequence 5 from Patent US 7811577",
            "Source": "Synthetic construct",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Frequent Amino Acids": "KAI",
            "Absent Amino Acids": "DFHMNOPRSUY",
            "Basic Residues": 9,
            "Acidic Residues": 6,
            "Hydrophobic Residues": 22,
            "Polar Residues": 23,
            "Positive Residues": 9,
            "Negative Residues": 6,
            "Mass": 4892.91,
            "PI": 9.07,
            "Net Charge": 3,
            "Hydrophobicity": 0.2,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_10753",
                    "Similarity": 1.0,
                    "Sequence": "CCGGIKKEIEAIKKEQEAIKKLLQLTVWGIKALAAAIA"
                },
                {
                    "SPADE_ID": "SPADE_UN_10762",
                    "Similarity": 1.0,
                    "Sequence": "GCCGGIKKEIEAIKKEQEAIKKKIEAIEKLLQLTVWGIKALAAAIA"
                },
                {
                    "SPADE_ID": "SPADE_UN_10785",
                    "Similarity": 1.0,
                    "Sequence": "CCGGLLQLTVWGIKQLQARILAIKKEIEAIKKEQEAIKKKIEAI"
                }
            ]
        }
    }
}